Overview

A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section

Status:
Completed
Trial end date:
2014-09-30
Target enrollment:
0
Participant gender:
Female
Summary
This is a randomized trial comparing oxytocin versus oxytocin + syntometrine in the prevention of post partum haemorrhage in patients undergoing caesarean section
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Pretoria
Treatments:
Ergonovine
Oxytocin
Syntometrine
Criteria
Inclusion Criteria:

- Pregnant women delivering by caesarean section older than 18 years willing and able to
give informed consent

Exclusion Criteria:

- • Women not willing or women not able to provide consent

- Women who have a classical caesarean section

- Women younger than 18 years of age

- Women with any of the following conditions will be excluded (ergometrine
contra-indicated in patients with these conditions).

- Pre- eclampsia

- Eclampsia,

- Uncontrolled hypertension (hypertension defined as systolic blood pressure more
than 140 mm Hg and diastolic blood pressure more than 90 mm Hg)

- Any cardiac lesion

- Impaired liver function

- Impaired kidney function

- Hypersensitivity to any of the active ingredients of the preparations that will
be used (Syntometrine® or Syntocinon®)

- Occlusive vascular disease

- Autoimmune vasculitis